| A Phase II Clinical Trial of Artificial Intelligence-assisted One-stop Radiotherapy for Breast Cancer After Breast-conserving Surgery (NCT06686459) | Sun Yat-sen University | 2025-04-06 |
| Hypofractionated vs. Conventional Chemoradiotherapy After Induction Chemo-immunotherapy for Unresectable Esophageal Squamous Cell Carcinoma (NCT06912074) | Sun Yat-sen University | 2025-04-05 |
| A Phase ll Study of Neoadjuvant Short-course Radiotherapy Followed by Ivonescimab and Chemotherapy in pMMR/MSS Locally Advanced Rectal Cancer (NCT06919510) | Sun Yat-sen University | 2025-04-01 |
| Liver Cancer Prognosis Investigation Study (NCT06623734) | Sun Yat-sen University | 2025-04-01 |
| Paclitaxel Polymersomes + Carboplatin + Adebelimab: Neoadjuvant Phase Ⅱ Single-Arm Study for Resectable Mucosal Melanoma (NCT07336979) | Sun Yat-sen University | 2025-03-20 |
| Phase II Study of PD-1 Antibody Combined With Radiotherapy in Recurrent or Metastatic Adrenal Cortical Carcinoma (NCT06587802) | Sun Yat-sen University | 2025-03-14 |
| Prostate Cryoablation Combined With Metronomic Cyclophosphamide for Metastatic Prostate Cancer (NCT06854250) | Sun Yat-sen University | 2025-03-01 |
| Sodium Bicarbonate for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma. (NCT06854510) | Sun Yat-sen University | 2025-02-21 |
| Toripalimab vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma (NCT06712888) | Sun Yat-sen University | 2025-02-17 |
| Development and Validation of a Deep Learning Model to Predict Distant Metastases in Nasopharyngeal Carcinoma Using Whole Slide Imaging and MRI (NCT06831357) | Sun Yat-sen University | 2025-02-15 |
| Efficacy and Safety of Zuberitamab Combined with Bendamustine, Followed by Monotherapy Maintenance, in Treatment-naïve Follicular Lymphoma (NCT06757894) | Sun Yat-sen University | 2025-02-01 |
| A Phase I/II Study of Golidocitinib Combined with Pomalidomide in R/R PTCL (NCT06855823) | Sun Yat-sen University | 2025-01-14 |
| Safety and Efficacy of R-CMOP Versus R-CHOP in the Initial Treatment of DLBCL (NCT06760039) | Sun Yat-sen University | 2025-01-10 |
| DYNAMICS-LYNCH：DNA Methylation Analysis in Stool for Screening of Lynch Syndrome-Associated Colorectal Cancer (NCT06772844) | Sun Yat-sen University | 2025-01-10 |
| Vunakizumab in Adults with Spondyloarthritis (NCT06770088) | Sun Yat-sen University | 2025-01-10 |
| GAPP Induction and Concurrent Chemoradiotherapy Followed by Toripalimab Maintenance for Nasopharyngeal Carcinoma. (NCT06851247) | Sun Yat-sen University | 2025-01-03 |
| HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma (NCT06737913) | Sun Yat-sen University | 2025-01-03 |
| High-dose Methotrexate Combined with Thiotepa and Zanubrutinib in the Treatment of Newly Diagnosed PCNSL (MTZ) (NCT06646211) | Sun Yat-sen University | 2025-01-01 |
| TACE Combined Surgery for the Resectable Huge HCC (NCT06898398) | Sun Yat-sen University | 2025-01-01 |
| Probiotics in Advanced Urothelial Carcinoma (NCT06904573) | Sun Yat-sen University | 2025-01-01 |
| Bortezomib Plus Cisplatin in Recurrent or Metastatic Breast Cancer (NCT06900647) | Sun Yat-sen University | 2025-01-01 |
| SBRT Combined with Camrelizumab and Apatinib for Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma. (NCT06739317) | Sun Yat-sen University | 2025-01-01 |
| Oral Chemotherapy, Targeted Therapy and Immunotherapy With/Without Radiotherapy as 3rd- or Later-line Therapy for Advanced MSS/pMMR Colorectal Cancer (NCT06764680) | Sun Yat-sen University | 2024-12-31 |
| An Exploratory Study on the Failure of Immunotherapy With Voronib Combined With Everolimus (NCT06730672) | Sun Yat-sen University | 2024-12-30 |
| Fruquintinib After ICIs Treatment in Unresectable Hepatocellular Carcinoma (NCT06446154) | Sun Yat-sen University | 2024-12-27 |
| Ivonescimab Combined with Chemotherapy As First-line Treatment of Relapsed or Metastatic Thymic Cancer: a Prospective, Single Arm, Phase II Trial (NCT06750952) | Sun Yat-sen University | 2024-12-20 |
| The Optimal Radioimmunotherapy Combinations for Advanced TNBC (NCT06735131) | Sun Yat-sen University | 2024-12-20 |
| Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Centrally Located Early-stage Non-small Cell Lung Cancer (NCT06730295) | Sun Yat-sen University | 2024-12-10 |
| ctDNA-MRD Guided Consolidation Toripalimab in Stage IB-IIIA NSCLC (NCT06426511) | Sun Yat-sen University | 2024-12-01 |
| A Clinical Study Based on FAPI-PET/CT Technology to Predict Pathological Complete Response After Neoadjuvant Chemoradiotherapy for MSS Rectal Cancer (NCT06608537) | Sun Yat-sen University | 2024-12-01 |
| Miti-gene Recurrence Score in HR+/HER2- Chinese Breast Cancer Patients (NCT07052734) | Sun Yat-sen University | 2024-12-01 |
| Clinical Study on the Safety, Efficacy and Pharmacokinetics of Telpegfilgrastim in Pediatric Cancer Patients with Chemotherapy (NCT06857292) | Sun Yat-sen University | 2024-12-01 |
| Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer (NCT06719700) | Sun Yat-sen University | 2024-11-30 |
| Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer (NCT06734702) | Sun Yat-sen University | 2024-11-30 |
| Nab-TPC vs GP Combined With Camrelizumab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma (NCT06669611) | Sun Yat-sen University | 2024-11-27 |
| Anlotinib Plus Nab-Paclitaxels and S-1 for Patients with Advanced Biliary Tract Cancer As Second-Line Treatment (NCT06662877) | Sun Yat-sen University | 2024-11-25 |
| Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma (NCT06730308) | Sun Yat-sen University | 2024-11-20 |
| Cryoablation Plus Camrelizumab for Advanced Soft Tissue Sarcoma (NCT07602049) | Sun Yat-sen University | 2024-11-20 |
| WHO Mental Health Gap Action Program (mhGAP) for Improving Child Mental and Behavioral Disorder Service Quality in China (NCT06702410) | Sun Yat-sen University | 2024-11-20 |
| A Deep Learning Model for Diagnosing Lymph Node Metastasis in Nasopharyngeal Carcinoma(NPC) (NCT06829147) | Sun Yat-sen University | 2024-11-19 |
| Treatment with Intensity Modulated Radiotherapy on the Change of Cognitive Function in Nasopharyngeal Carcinoma Patients: a Prospective Cohort Study (NCT06695936) | Sun Yat-sen University | 2024-11-15 |
| Sintilimab Plus Rituximab Followed by R-CHOP Regimen in Untreated PMBL (NCT06742502) | Sun Yat-sen University | 2024-11-12 |
| Inhaling Penehyclidine to Prevent Perioperative Respiratory Adverse Events in Children at Risk Undergoing Sevoflurane Anesthesia (NCT06624696) | Sun Yat-sen University | 2024-11-12 |
| Comparison of Endoscopy and Esophagram for the Routine Evaluation of Anastomosis After McKeown Esophagectomy (NCT07043491) | Sun Yat-sen University | 2024-11-04 |
| A TTM-based Smoking Cessation Intervention in Helping Expectant Fathers to Quit Smoking and Maintain Abstinence (NCT06663475) | Sun Yat-sen University | 2024-11-04 |
| A Multicenter, Single-arm, Open-label Study Evaluating the Safety and Efficacy of AK112 Combined With Chemotherapy as First-line Treatment for Non-squamous NSCLC Patients With BRAIN Metastases and Negative Driver Genes (IVO BRAIN) (NCT06684873) | Sun Yat-sen University | 2024-11-02 |
| Photoacoustic Tomography in Assessment of Lower Extremity Artery Disease (NCT06579326) | Sun Yat-sen University | 2024-11-01 |
| Phase I Study of Umbilical Cord Blood Natural Killer (NK) Cell Therapy for Children With High-risk, R/R Neuroblastoma. (NCT06631391) | Sun Yat-sen University | 2024-11-01 |
| Orelabrutinib in Combination with R-CHOP for CD5-positive DLBCL Patients（Rocket Trial） (NCT06647940) | Sun Yat-sen University | 2024-11-01 |
| Umbilical Cord Blood NK Cell Therapy for High-Risk Pediatric Soft Tissue Sarcoma: Efficacy and Safety Study (NCT06848582) | Sun Yat-sen University | 2024-11-01 |
| Irinotecan Liposome Combined with S-1 in PD-1/L1 Inhibitor Refractory Recurrent or Metastatic NPC (NCT06657690) | Sun Yat-sen University | 2024-11-01 |
| Adjuvant PD-1 Blockade for High-risk Stage-II DMMR/MSI-H Colorectal Cancer (NCT06520683) | Sun Yat-sen University | 2024-11-01 |
| Nomogram for Predicting Biliary Complication (NCT06658665) | Sun Yat-sen University | 2024-11-01 |
| Neoadjuvant Umbrella Trial for Patients With Unresectable Stage III NSCLC Harboring Rare Mutations. (NCT06563999) | Sun Yat-sen University | 2024-11-01 |
| Zanubrutinib Plus Rituximab as Front-line Treatment for Mucosa-associated Lymphoid Tissue Lymphoma (MALT) (NCT06647732) | Sun Yat-sen University | 2024-10-30 |
| Arsenous Acid for Refractory Triple-Negative Breast Cancer (NCT06678048) | Sun Yat-sen University | 2024-10-23 |
| Sintilimab Plus AVD in Pediatric Low/Moderate Risk Hodgkin Lymphoma: A Phase II Study (NCT06848569) | Sun Yat-sen University | 2024-10-23 |
| Sintilimab With P-GEMOX Versus the P-GEMOX in the Teatment of Advanced-stage Extranodal Natural Killer/T Cell Lymphoma (NCT06583083) | Sun Yat-sen University | 2024-10-22 |
| TPC Combined With Cadonilimab VS. TPC Alone in Anti-PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma (NCT06664983) | Sun Yat-sen University | 2024-10-21 |
| Ablation of Pulmonary Oligometastasis Combined With System for Advanced Hepatocellular Carcinoma (NCT06644430) | Sun Yat-sen University | 2024-10-04 |
| Early Transjugular Intrahepatic Portosystemic Shunt for Advanced Hepatocellular Carcinoma (NCT06624098) | Sun Yat-sen University | 2024-10-01 |
| The Comparison of TACE-Lenvatinib With TACE-Lenvatinib-ablation for Intermediate Recurrent Hepatocellular Carcinoma (NCT06609850) | Sun Yat-sen University | 2024-10-01 |
| HAIC Compared With TACE in Huge Hepatocellular Carcinoma (NCT06641713) | Sun Yat-sen University | 2024-10-01 |
| Second-line Systemic Therapy Combined with SBRT for HCC with Oligoprogression After Standard First-line Systemic Treatment (NCT06592612) | Sun Yat-sen University | 2024-10-01 |
| Donafenib as Adjuvant Therapy Following Ablation for Recurrent HCC (NCT06609876) | Sun Yat-sen University | 2024-10-01 |
| dTACE-HAIC Combined With Bevacizumab and Atezolizumab for Huge Hepatocellular Carcinoma (NCT06609863) | Sun Yat-sen University | 2024-10-01 |
| TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT (NCT06622031) | Sun Yat-sen University | 2024-10-01 |
| Reduction of Postoperative Radiotherapy in Head and Neck Squamous Cell Carcinoma (NCT06630780) | Sun Yat-sen University | 2024-09-26 |
| Neoajuvant Tislelizumab Combined with Chemotherapy for Initially Unresectable Stage IIIA/N2 Non-small Cell Lung Cancer (NCT06614231) | Sun Yat-sen University | 2024-09-20 |
| 2 Courses of Concurrent Cisplatin Chemoradiotherapy After Surgery for High-risk Head and Neck Squamous Cell Carcinoma (NCT06492460) | Sun Yat-sen University | 2024-09-20 |
| Systemic Therapy Alone or With Stereotactic Body Radiotherapy for Oligometastatic Kidney Cancer (STROKER Study) (NCT06726421) | Sun Yat-sen University | 2024-09-18 |
| Hematoporphyrin Photodynamic Therapy for Esophageal Cancer (NCT06437288) | Sun Yat-sen University | 2024-09-18 |
| SBRT Followed by Chemoimmunotherapy of Toripalimab Plus Docetaxel and Cisplatin for Larynx Preservation in Patients with Locally Regionally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx (NCT06611137) | Sun Yat-sen University | 2024-09-11 |
| Tumor Neoantigen Vaccine SarVac Combined With Tumor Specific Lymphocyte Reinfusion in the Treatment of Advanced Sarcoma (NCT07648069) | Sun Yat-sen University | 2024-09-03 |
| Modified Orbital Decompression in the Treatment of Moderate-to-severe Grave's Ophthalmopathy (NCT06588764) | Sun Yat-sen University | 2024-09-01 |
| Neoadjuvant HAIC and PD-1 Plus Adjuvant PD-1 for High-risk Recurrent HCC (NCT06467799) | Sun Yat-sen University | 2024-09-01 |
| Neoadjuvant RC48 Plus Carboplatin for HER2-expressing Advanced Ovarian Cancer (NCT06574763) | Sun Yat-sen University | 2024-09-01 |
| Oral Immunonutrition Therapy to Reduce Acute Toxicity After Neoadjuvant Chemoradiotherapy Pancreatic Cancer Patients (NCT06736678) | Sun Yat-sen University | 2024-08-26 |
| TPC VS. GP Induced Chemotherapy Combined With Nimotuzumab and Toripalimab in the Treatment of Locally Advanced Nasopharyngeal Carcinoma (NCT06561763) | Sun Yat-sen University | 2024-08-20 |
| Clinical Study of Radical Right Hemicolectomy Versus Radical Right Hemicolectomy Combined with Indocyanine Green Fluorescence Imaging Lymphatic Tracer Dissection for the Treatment of Right Colon Cancer (NCT06485609) | Sun Yat-sen University | 2024-08-10 |
| Adaptive Therapy for Post-Second-Line Advanced Breast Cancer (NCT06533722) | Sun Yat-sen University | 2024-08-04 |
| Concurrent Nab-paclitaxel with Intensity-modulated Radiation Therapy in Patients with Stage III-IVa Nasopharyngeal Carcinoma (NCT06611150) | Sun Yat-sen University | 2024-08-02 |
| The Impact of Medication Timing Adjustment on the Effect of Novel Hormonal Therapy (NCT06505278) | Sun Yat-sen University | 2024-08-01 |
| Adaptive Hypofractionated Radiotherapy for Locally Advanced NSCLC Based on Dynamic Enhanced MRI (NCT06545747) | Sun Yat-sen University | 2024-08-01 |
| Selinexor in Combination With R-CHOP as the First-line Therapy for TP53-mutated DLBCL Patients (Smart Trial) (NCT06517511) | Sun Yat-sen University | 2024-08-01 |
| Ablation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular Carcinoma (NCT06550921) | Sun Yat-sen University | 2024-08-01 |
| Under Whole-course of Immunotherapy, Gradient Fractionated RT with CCT Versus CFRT with CCT for LANPC Who Achieved PR Post Induction Chemotherapy. (NCT06675214) | Sun Yat-sen University | 2024-07-30 |
| Efficacy and Safety of Organoid-Based Drug Sensitivity Screening to Guide the Treatment of mCRPC Patients Progressed After First-line Treatment (NCT06529549) | Sun Yat-sen University | 2024-07-24 |
| Neoadjuvant SBRT Combined With Lenvatinib and Pucotenlimab for Resectable Hepatocellular Carcinoma (NCT06524466) | Sun Yat-sen University | 2024-07-23 |
| Cetuximab, Irinotecan, Toripalimab in RAS/BRAF Wild-type Ultraselected Right-sided Colorectal Cancer Study (NCT06547203) | Sun Yat-sen University | 2024-07-18 |
| Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations (NCT06517953) | Sun Yat-sen University | 2024-07-17 |
| Prognostic Significance of the Uncertain Resection in NSCLC (NCT06511661) | Sun Yat-sen University | 2024-07-16 |
| GOS and the Management of Hyperuricemia (NCT06630377) | Sun Yat-sen University | 2024-07-15 |
| Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC (NCT06197776) | Sun Yat-sen University | 2024-07-15 |
| Promoting Atrial Fibrillation Screening in Primary Care (NCT06458829) | Sun Yat-sen University | 2024-07-01 |
| Comparison of General Anesthesia Hemodynamics Between R and P in Patients Undergoing Laparoscopic Hepatectomy (NCT06714669) | Sun Yat-sen University | 2024-06-20 |
| HAIC Combined With Adebrelimab Plus Apatinib as the First-line Treatment for HCC in BCLC Stage C: An Open-label, Single-arm, Phase II Study (NCT06482008) | Sun Yat-sen University | 2024-06-19 |
| GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy for Nasopharyngeal Carcinoma (NCT06455410) | Sun Yat-sen University | 2024-06-18 |
| Effectiveness of Pucotenlimab Combined With Standard Chemotherapy Regimen (NCT06456892) | Sun Yat-sen University | 2024-06-06 |
| Liposomal Irinotecan Plus Bevacizumab in Irinotecan-refractory Metastatic Colorectal Cancer (NCT06434090) | Sun Yat-sen University | 2024-06-05 |